Treatment With a New Benzimidazole Derivative Bearing a Pyrrolidine Side Chain Overcomes Sorafenib Resistance in Hepatocellular Carcinoma
Scientific Reports - United Kingdom
doi 10.1038/s41598-019-53863-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 21, 2019
Authors
Publisher
Springer Science and Business Media LLC